Twenty-three-year-old Dominique Lasconi Mulamba from the Democratic Republic of the Congo has been suspended by the Athletics Integrity Unit (AIU) for doping.
On August 3, 2024, Mulamba competed in the 100m sprint heats at the 2024 Paris Olympic Games. He finished in eighth position. The following dayhe provided an “out-of-competition” urine sample. On the 10th of August, the International Testing Agency (ITA) notified the Athlete that analysis of the sample had revealed the presence of a metabolite of stanozolol, 17-epistanozolol-N-glucuronide. Stanozolol is a prohibited substance according to the World Anti-Doping Agency’s 2024 Prohibited List, under the category S1.1A Anabolic Androgenic Steroids. It is a non-specified substance and is prohibited at all times. Mulamba was also informed that he was subject to a provisional suspension.
"Stanozolol is unsuited for sprinters": Paris Olympics sprinter Mulamba banned 4 years for doping with anabolic steroid – https://t.co/IW2bzomaAr, For the best experience read this on Sportstar App. https://t.co/27MgXPPJPa
— K.P. Mohan (@kaypeem) May 15, 2025
On August 21, the athlete was informed that a provisional suspension was imposed and that following the determination of whether he had committed an anti-doping rule violation (ADRV) the International Olympic Committee (IOC) would refer the determination of further consequences beyond the Olympic Games to the AIU on behalf of WA.
His B Sample confirmed the presence of a metabolite of stanozolol, and therefore, it was undisputed that he had committed an ADRV. The consequences under the IOC ADR, Mulamba, on October 9, signed and returned an Agreement on consequences, expressly agreeing to the consequences of the ADRV pursuant to the IOC ADR.
The Disciplinary Panel, comprised of Mr Conny Jörneklint, was appointed to hear this matter.
In contesting the Consequences set out by the WA ADR, the Athlete argued that the analyses of the Samples did not comply with the requirements of the International Standards for Laboratories (ISL) and therefore should be disregarded, that the ADRVs were not intentional and therefore the applicable Consequences were eligible for a reduction based on the seriousness of the offence and the specific circumstances, and that he should be entitled to a reimbursement of his legal costs.
The athlete was not successful in pointing to the source of the metabolite of stanozolol. The conclusion is that the period of Ineligibility should be four years.
The period of ineligibility started April 28, 2025; however, credit was given for the period Mulamba was provisionally suspended. Mulamba had not competed since the 2024 Olympic Games in Paris; therefore, no additional consequences or disqualifications were imposed. The decision is subject to appeal to the Court of Arbitration for Sport.
*Featured image source: Dominique Lasconi Mulamba of Team Democratic Republic of the Congo (R) can challenge his ban in an appeal to the Court of Arbitration for Sport. | Photo Credit: CHRISTIAN PETERSEN
